Pocapavir
≥98%
- Product Code: 102104
CAS:
146949-21-5
| Molecular Weight: | 423.72 g./mol | Molecular Formula: | C₂₁H₁₇Cl₃O₃ |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2-8℃ |
Product Description:
Pocapavir is primarily used in the research and development of antiviral treatments, particularly for combating enterovirus infections. It has shown potential in inhibiting viral replication by targeting the viral capsid, making it a candidate for addressing severe cases of enterovirus-related diseases, such as acute flaccid myelitis and hand, foot, and mouth disease. Studies have explored its efficacy in reducing viral load and improving clinical outcomes, especially in immunocompromised patients. However, its use is still largely experimental, with ongoing clinical trials to determine its safety, effectiveness, and potential resistance issues. Pocapavir represents a promising avenue for developing targeted antiviral therapies in the future.
Product Specification:
| Test | Specification |
|---|---|
| Appearance | White To Off-White Solid |
| Purity (%) | 100 |
| Infrared Spectrum | Conforms To Structure |
| NMR | Conforms To Structure |
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.005 | 10-20 days | £229.61 |
+
-
|
| 0.010 | 10-20 days | £324.87 |
+
-
|
Pocapavir
Pocapavir is primarily used in the research and development of antiviral treatments, particularly for combating enterovirus infections. It has shown potential in inhibiting viral replication by targeting the viral capsid, making it a candidate for addressing severe cases of enterovirus-related diseases, such as acute flaccid myelitis and hand, foot, and mouth disease. Studies have explored its efficacy in reducing viral load and improving clinical outcomes, especially in immunocompromised patients. However, its use is still largely experimental, with ongoing clinical trials to determine its safety, effectiveness, and potential resistance issues. Pocapavir represents a promising avenue for developing targeted antiviral therapies in the future.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
£0.00
£0.00
Total :